Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers May 29, 2017
Pharmacy Choice - News - Front Page Healthcare News - May 29, 2017

Pharmacy News

 Front Page Healthcare News
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

5/28/17 - 5 Top NASDAQ Biotech Stocks: Nutraceutical Gained 48.93 Percent
Last week the Congressional Budget Office revealed the GOP replacement to Obamacare would end up nixing insurance coverage to 26 million american citizens by 2026 in an attempt to reduce $119 billion over the next decade. FDA head Scott Gottlieb announced it would remove the federal hiring freeze to his agency. Nutraceutical CytRx MannKind MEI Phar
5/28/17 - CBO report
Many of us retired folks in Green Valley might be unaware of the personal effects of such healthcare legislation, because we feel secure in our status as Medicare or Tricare enrollees. The AHCA cuts $834 billion from Medicaid which essentially ends that program as we know it. One in five people with Medicare who also rely on Medicaid will lose thei
5/28/17 - Contrasting views of health care report [The Herald Bulletin, Anderson, Ind.]
May 28 ANDERSON As could be anticipated, a Republican and a Democrat representing Hoosiers are reacting differently to the Congressional Budget Office analysis of the health care act passed by the U.S. House. The nonpartisan CBO on Wednesday reported that the American Health Care Act passed by the U.S. House could result in an additional 23 mil
5/28/17 - Findings from Bentley University Broaden Understanding of Clinical Trials and Studies (Timelines of translational science: From technology initiation...
By a News Reporter-Staff News Editor at Medical Letter on the CDC& FDA Current study results on Clinical Research- Clinical Trials and Studies have been published. We examined timelines of translational science for 138 drugs and biologicals approved by the FDA from 2010-2014 using an analytical model of technology maturation. " Our news journalis
5/28/17 - Findings from Mercy Health Provides New Data on Information Technology (Constructing the informatics and information technology foundations of a...
By a News Reporter-Staff News Editor at Medical Letter on the CDC& FDA Current study results on Information Technology have been published. The FDA funded a demonstration by Mercy Health wherein prototype UDIs were incorporated into its electronic information systems. " The demonstration included many stakeholders: multiple Mercy departments,...
5/28/17 - Insurance changes impact area residents [The Sedalia Democrat, Sedalia, Mo.]
May 27 On May 4, the U.S. House of Representatives voted 217 to 213 to repeal the Affordable Care Act of 2010, more commonly referred to as "ObamaCare." Based on the reports I have heard, Pettis County will be one of those counties. " According to the Kansas City Star, that decision will affect about 67,000 members in western Missouri, Pettis Cou
5/28/17 - LETTER: Steve King is no health care hero
With interest, I read The Journal's recent article about the children flown to Sioux City for medical care after surviving a terrible bus accident in Tanzania. Meanwhile, in King's home country that is America, he voted in support of the American Health Care Act, legislation passed by the U.S. House on May 4 now awaiting action in the Senate. Accor
5/28/17 - New Heart Disease Study Findings Have Been Reported by Researchers at Hallym University Sacred Heart Hospital (Acute kidney injury can predict...
New Heart Disease Study Findings Have Been Reported by Researchers at Hallym University Sacred Heart Hospital. By a News Reporter-Staff News Editor at Heart Disease Weekly Investigators publish new report on Heart Disorders and Diseases- Heart Disease. Our news journalists obtained a quote from the research from Hallym University Sacred Heart Hos
5/28/17 - OPINION: Sunday roundup [Herald-Times, Bloomington, Ind.]
The latest blow to rational health care policy came when the Trump administration asked for a second deadline extension to respond to a lawsuit filed by the GOP- led House that challenges subsidies for low-income Americans buying health insurance on Obamacare exchanges.... The Kaiser Family Foundation estimates that without the subsidies, the cost
5/28/17 - Purchase And Successive Delivery Of Non-woven Disposable Medical Devices. [TendersInfo (India)]
Contract notice: Purchase and successive delivery of non-woven disposable medical devices. All sterile products with the confirmation:- Compliance with PN EN 13 795- Validation reports for sterilization in accordance with PN EN ISO 11 135-1- Technical sheets on the parameters of materials used in the production of the product- Technical documentati
5/28/17 - Researchers Submit Patent Application, "Method of Treating Hyperlipidemia and Atherosclerosis with Mir-30c", for Approval (USPTO 20170121713)
By a News Reporter-Staff News Editor at Heart Disease Weekly From Washington, D.C., NewsRx journalists report that a patent application by the inventors Hussain, Mahmood; Soh, James, filed on January 12, 2017, was made available online on May 11, 2017. The patent's assignee is The Research Foundation for The State University of New York. News edi
5/28/17 - Safety events common for pharmaceuticals and biologics after FDA approval
By a News Reporter-Staff News Editor at Medical Letter on the CDC& FDA Among more than 200 new pharmaceuticals and biologics approved by the U.S. Food and Drug Administration from 2001 through 2010, nearly a third were affected by a postmarket safety event such as issuance of a boxed warning or safety communication, according to a study published
5/28/17 - Savvy Senior: Should all baby boomers get tested for hepatitis C? hammer
QUESTION: I've recently read that all baby boomers should get tested for hepatitis C. Is this really necessary, and, if so, what are the testing and treatment procedures? Both the U.S. Preventive Services Task Force and the Centers for Disease Control and Prevention recommend that all baby boomers- people born from 1945 through 1965- get a hepatiti
5/28/17 - TrumpCare would result in less service, bigger bills
This bill would cut off coverage of family planning services, cancer screening services and STD screening provided by Planned Parenthood across the nation. The AHCA would prevent Planned Parenthood from receiving Title X family planning funds or Medicaid reimbursement for any service it provides. In the past, this led to Medicaid covering more than
5/27/17 - "Combination Pharmaceutical Composition and Methods of Treating Diseases Or Conditions Associated with Neurodegenerative Diseases" in Patent...
"Combination Pharmaceutical Composition and Methods of Treating Diseases Or Conditions Associated with Neurodegenerative Diseases" in Patent Application Approval Process. By a News Reporter-Staff News Editor at Obesity, Fitness& Wellness Week A patent application by the inventor Epshtein, Oleg Iliich, filed on January 3, 2017, was made available
5/27/17 - "Method for Preparing Azetidinone Compound and Intermediate of Azetidinone Compound" in Patent Application Approval Process (USPTO 20170121281)
By a News Reporter-Staff News Editor at Obesity, Fitness& Wellness Week A patent application by the inventors BAI, Hua; ZHAO, Xuyang; ZHANG, Yuncai; LI, Xufei; ZHANG, Yong; XU, Dezhou; ZHANG, Li; XU, Xiaojie; ZHU, Qifeng; WANG, Xiaoming; YANG, Zhiqing; ZHONG, Zehua; ZHANG, Jian, filed on June 5, 2015, was made available online on May 11, 2017, ac
5/27/17 - Abide Therapeutics Announces Dosing of First Subject in fMRI Imaging Study to Investigate Brain Activity Patterns Associated with ABX-1431
By a News Reporter-Staff News Editor at Obesity, Fitness& Wellness Week Abide Therapeutics, a developer of innovative pharmaceuticals, announced initiation of dosing in a Phase 1 study using functional magnetic resonance imaging to evaluate patterns of neural activity in the brain associated with oral administration of ABX-1431, a first-in-class.
5/27/17 - Accelerated FDA approval and pricey drugs make a rotten combo, doctors argue [Tehran Times (Iran)]
Should drugs that win FDA approval on an accelerated pathoften without strong evidence of efficacycommand the same high prices as products that undergo the full menu of agency scrutiny? The ideaswhich include lower prices until drugs prove themselves out in confirmatory trialscome amid an unprecedented debate over the price tags on drugs in the U.S
5/27/17 - Analysis of the Congressional Budget Office's Estimate of the House-Passed Affordable Care Act Repeal Legislation
The AHCA would benefit wealthy households and insurance and drug companies at the expense of low and moderate-income individuals who would be harmed by radical cuts to Medicaid and much reduced premium tax credits to purchase health care in the Affordable Care Act's marketplaces. CBO/JCT project that losses will occur due to the proposal's repeal o
5/27/17 - ANOTHER OPINION CBO brutalizes GOP's health plan
There's no honor in keeping a promise to repeal the Obama law, which is how Lewis and others have defended their AHCA support, when the replacement would gut Medicaid, a safety-net program for children and the elderly, and would leave millions more Americans without health insurance. On Wednesday, the nonpartisan Congressional Budget Office release
5/27/17 - Attorney General Becerra Announces $33M Nationwide Settlement After Maker of Tylenol, Motrin, Benadryl Produced Adulterated Medicine
California Attorney General Xavier Becerra issued the following news release:. California Attorney General Xavier Becerra announced a $33 million settlement with drug manufacturer Johnson& Johnson after it violated federal regulations between 2009 and 2011 that ensure the quality of certain medicines, including many consumed by children.
5/27/17 - BioCryst gets a big boost from its latest HAE data, but it still faces a dangerous high wire act and giant rivals [Tehran Times (Iran)]
A little more than a year ago, shares of Research Triangle Park, NC- based BioCryst$ BCRX were crushed by a failed Phase II trial for their lead drug for hereditary angioedema, or HAE. Setbacks like that are not new for BioCryst. But the biotech turned to another HAE drug coming up the pipeline.
5/27/17 - Calcimedica gets fast track status for CRAC channel inhibitor `CM4620` to treat acute pancreatitis [Tehran Times (Iran)]
Privately-held CalciMedica, announced that it received Fast-Track designation from the US Food and Drug Administration for its lead clinical compound, CM4620, a novel, calcium release-activated calcium channel inhibitor, for the treatment of acute pancreatitis. "We are very pleased to receive Fast-Track designation for CM4620, which may allow us t
5/27/17 - Cancer scientist tries to help others as he battles his own Stage 4 cancer [The San Diego Union-Tribune]
The lanky, low-key and bearded Point Loma Heights resident has a doctorate in medicinal chemistry and is the co-inventor of Zykadia, an FDA- approved lung cancer drug made by his employer, the massive Switzerland- based pharmaceutical company, Novartis. Four years later, that personal project, with the help of the advocacy group Fight Colorectal Ca
5/27/17 - Challenging year as waits have increased
The Shrewsbury and Telford Hospital NHS Trust annual report gives an insight into the challenges experienced by the hospitals between March 2016 and March this year. About 80 per cent of A&E patients were admitted or discharged within four hours at Royal Shrewsbury Hospital and Telford's Princess Royal. Infections Simon Wright, chief executive of t
Articles(s): 1 - 25 of 250     Next >>     Go To Page:


© 2017 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
RxSchool
Telepharmacy- Remote Delivery of Pharmacy Services
This lesson is supported by:
RxSchool
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool
Drug Therapy Management Series Part III: Geriatric Disorders
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415